Dermatology Search
Dermatology Dermatology
scleroderma
SCLERODERMA
Scleroderma is a connective tissue disorder characterized by skin thickening and fibrosis. It is rare, autoimmune and chronic.
It has an idiopathic cause and not contagious.
Early microvascular damage, mononuclear cell infiltrates and slowly developing fibrosis are the important features of the tissue lesions.
The leading causes of death are pulmonary fibrosis and pulmonary arterial hypertension.
Drug Information

Indication: Erectile dysfunction.

Indication: Erectile dysfunction.

Indication: CHD: Chronic stable angina pectoris; HTN.

Indication: Erectile dysfunction.

Indication: Acute & chronic rheumatic fever, RA, bronchial asthma, myositis, dermatitis.

Bufencon
betamethasone dipropionate + betamethasone disodiu...

Indication: Rheumatic disorders, collagen disease, allergic states.

Diprospan
betamethasone dipropionate + betamethasone disodiu...

Indication: Adjunctive treatment of acute & chronic corticosteroid-responsive disorders.

Indication: Erectile dysfunction.

Indication: Erectile dysfunction.

Indication: Class II & III pulmonary arterial HTN in adult patients. Primary pulmonary & pulmonary HTN associated ...

1  /  3
1  /  3
Editor's Recommendations
Most Read Articles
Sodium lauryl sulphate-free moisturizers are gentler on skin
Tristan Manalac, 25 Sep 2019
Aqueous cream moisturizers that do not contain sodium lauryl sulphate (SLS) are less irritating to the skin than SLS-containing ones, while achieving similar levels of hydration and skin barrier integrity, according to a recent Singapore study.
Generalized, local dry skin common among middle-aged adults, seniors
24 Sep 2019
Generalized and localized dry skin is prevalent among middle-aged and elderly adults, a recent study has found.
Disease severity, itch, pain linked to perceived importance of skin clearance in AD, psoriasis
29 Sep 2019
There is a strong request for almost complete or complete skin clearance among patients with psoriasis or atopic dermatitis (AD), according to a recent study.
Original New Drug Application Approvals by US FDA (01 - 15 October 2019)
Yesterday
New drug applications approved by US FDA as of 01 - 15 October 2019 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.